APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prophylactic Gamma Globulin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prophylactic Gamma Globulin Market Outlook and Growth Opportunities 2026

Report ID 174029060422 December 2025209 pages

Choose your research edition.

Industry ResearchProphylactic Gamma Globulin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prophylactic Gamma Globulin Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Prophylactic Gamma Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prophylactic Gamma Globulin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Prophylactic Gamma Globulin Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Prophylactic Gamma Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prophylactic Gamma Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prophylactic Gamma Globulin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prophylactic Gamma Globulin market include CNBG, Takeda, Shenzhen Weiguang Biological, Beijing Tiantan Biological, CBPO, Sichuan Yuanda Shuyang, Shanghai RAAS, Pacific Shuanglin Bio-pharmacy and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prophylactic Gamma Globulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prophylactic Gamma Globulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prophylactic Gamma Globulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prophylactic Gamma Globulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Prophylactic Gamma Globulin Segment by Company

CNBG

Takeda

Shenzhen Weiguang Biological

Beijing Tiantan Biological

CBPO

Sichuan Yuanda Shuyang

Shanghai RAAS

Pacific Shuanglin Bio-pharmacy

Grifols

Hualan Biological

Beijing Bohui Innovation Biotechnology

Baxter

Octapharma

LFB Group

Kedrion Biopharma

BPL

Biotest

ADMA Biologics

Prophylactic Gamma Globulin Segment by Type

IVIg Liquid

IVIg Powder

Prophylactic Gamma Globulin Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Prophylactic Gamma Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prophylactic Gamma Globulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prophylactic Gamma Globulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prophylactic Gamma Globulin significant trends, drivers, influence factors in global and regions.

6. To analyze Prophylactic Gamma Globulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prophylactic Gamma Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prophylactic Gamma Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prophylactic Gamma Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prophylactic Gamma Globulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prophylactic Gamma Globulin industry.

Chapter 3: Detailed analysis of Prophylactic Gamma Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prophylactic Gamma Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prophylactic Gamma Globulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prophylactic Gamma Globulin Industry Trends Table 2. Prophylactic Gamma Globulin Industry Drivers Table 3. Prophylactic Gamma Globulin Industry Opportunities and Challenges Table 4. Prophylactic Gamma Globulin Industry Restraints Table 5. Global Prophylactic Gamma Globulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prophylactic Gamma Globulin Revenue Share by Company (2021-2026) Table 7. Global Prophylactic Gamma Globulin Sales Volume by Company (k units) & (2021-2026) Table 8. Global Prophylactic Gamma Globulin Sales Volume Share by Company (2021-2026) Table 9. Global Prophylactic Gamma Globulin Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prophylactic Gamma Globulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prophylactic Gamma Globulin Key Company Manufacturing Base & Headquarters Table 12. Global Prophylactic Gamma Globulin Company, Product Type & Application Table 13. Global Prophylactic Gamma Globulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prophylactic Gamma Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of IVIg Liquid Table 18. Significant Companies of IVIg Powder Table 19. Global Prophylactic Gamma Globulin Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Prophylactic Gamma Globulin Sales Volume by Type (2021-2026) & (k units) Table 21. Global Prophylactic Gamma Globulin Sales Volume by Type (2027-2032) & (k units) Table 22. Global Prophylactic Gamma Globulin Sales Volume Share by Type (2021-2026) Table 23. Global Prophylactic Gamma Globulin Sales Volume Share by Type (2027-2032) Table 24. Global Prophylactic Gamma Globulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Prophylactic Gamma Globulin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Prophylactic Gamma Globulin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Prophylactic Gamma Globulin Sales Value Share by Type (2021-2026) Table 28. Global Prophylactic Gamma Globulin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Autoimmune Disease Table 30. Significant Companies of Immunodeficiency Table 31. Significant Companies of Acute Infection Table 32. Global Prophylactic Gamma Globulin Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Prophylactic Gamma Globulin Sales Volume by Application (2021-2026) & (k units) Table 34. Global Prophylactic Gamma Globulin Sales Volume by Application (2027-2032) & (k units) Table 35. Global Prophylactic Gamma Globulin Sales Volume Share by Application (2021-2026) Table 36. Global Prophylactic Gamma Globulin Sales Volume Share by Application (2027-2032) Table 37. Global Prophylactic Gamma Globulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prophylactic Gamma Globulin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Prophylactic Gamma Globulin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Prophylactic Gamma Globulin Sales Value Share by Application (2021-2026) Table 41. Global Prophylactic Gamma Globulin Sales Value Share by Application (2027-2032) Table 42. Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Prophylactic Gamma Globulin Sales by Region (2021-2026) & (k units) Table 44. Global Prophylactic Gamma Globulin Sales Market Share by Region (2021-2026) Table 45. Global Prophylactic Gamma Globulin Sales by Region (2027-2032) & (k units) Table 46. Global Prophylactic Gamma Globulin Sales Market Share by Region (2027-2032) Table 47. Global Prophylactic Gamma Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prophylactic Gamma Globulin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Prophylactic Gamma Globulin Sales Value Share by Region (2021-2026) Table 50. Global Prophylactic Gamma Globulin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Prophylactic Gamma Globulin Sales Value Share by Region (2027-2032) Table 52. Global Prophylactic Gamma Globulin Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Prophylactic Gamma Globulin Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Prophylactic Gamma Globulin Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Prophylactic Gamma Globulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Prophylactic Gamma Globulin Sales by Country (2021-2026) & (k units) Table 57. Global Prophylactic Gamma Globulin Sales Market Share by Country (2021-2026) Table 58. Global Prophylactic Gamma Globulin Sales by Country (2027-2032) & (k units) Table 59. Global Prophylactic Gamma Globulin Sales Market Share by Country (2027-2032) Table 60. Global Prophylactic Gamma Globulin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Prophylactic Gamma Globulin Sales Value Market Share by Country (2021-2026) Table 62. Global Prophylactic Gamma Globulin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Prophylactic Gamma Globulin Sales Value Market Share by Country (2027-2032) Table 64. CNBG Company Information Table 65. CNBG Business Overview Table 66. CNBG Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. CNBG Prophylactic Gamma Globulin Product Portfolio Table 68. CNBG Recent Development Table 69. Takeda Company Information Table 70. Takeda Business Overview Table 71. Takeda Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Takeda Prophylactic Gamma Globulin Product Portfolio Table 73. Takeda Recent Development Table 74. Shenzhen Weiguang Biological Company Information Table 75. Shenzhen Weiguang Biological Business Overview Table 76. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio Table 78. Shenzhen Weiguang Biological Recent Development Table 79. Beijing Tiantan Biological Company Information Table 80. Beijing Tiantan Biological Business Overview Table 81. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio Table 83. Beijing Tiantan Biological Recent Development Table 84. CBPO Company Information Table 85. CBPO Business Overview Table 86. CBPO Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. CBPO Prophylactic Gamma Globulin Product Portfolio Table 88. CBPO Recent Development Table 89. Sichuan Yuanda Shuyang Company Information Table 90. Sichuan Yuanda Shuyang Business Overview Table 91. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio Table 93. Sichuan Yuanda Shuyang Recent Development Table 94. Shanghai RAAS Company Information Table 95. Shanghai RAAS Business Overview Table 96. Shanghai RAAS Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio Table 98. Shanghai RAAS Recent Development Table 99. Pacific Shuanglin Bio-pharmacy Company Information Table 100. Pacific Shuanglin Bio-pharmacy Business Overview Table 101. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio Table 103. Pacific Shuanglin Bio-pharmacy Recent Development Table 104. Grifols Company Information Table 105. Grifols Business Overview Table 106. Grifols Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Grifols Prophylactic Gamma Globulin Product Portfolio Table 108. Grifols Recent Development Table 109. Hualan Biological Company Information Table 110. Hualan Biological Business Overview Table 111. Hualan Biological Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Hualan Biological Prophylactic Gamma Globulin Product Portfolio Table 113. Hualan Biological Recent Development Table 114. Beijing Bohui Innovation Biotechnology Company Information Table 115. Beijing Bohui Innovation Biotechnology Business Overview Table 116. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio Table 118. Beijing Bohui Innovation Biotechnology Recent Development Table 119. Baxter Company Information Table 120. Baxter Business Overview Table 121. Baxter Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Baxter Prophylactic Gamma Globulin Product Portfolio Table 123. Baxter Recent Development Table 124. Octapharma Company Information Table 125. Octapharma Business Overview Table 126. Octapharma Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Octapharma Prophylactic Gamma Globulin Product Portfolio Table 128. Octapharma Recent Development Table 129. LFB Group Company Information Table 130. LFB Group Business Overview Table 131. LFB Group Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. LFB Group Prophylactic Gamma Globulin Product Portfolio Table 133. LFB Group Recent Development Table 134. Kedrion Biopharma Company Information Table 135. Kedrion Biopharma Business Overview Table 136. Kedrion Biopharma Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio Table 138. Kedrion Biopharma Recent Development Table 139. BPL Company Information Table 140. BPL Business Overview Table 141. BPL Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. BPL Prophylactic Gamma Globulin Product Portfolio Table 143. BPL Recent Development Table 144. Biotest Company Information Table 145. Biotest Business Overview Table 146. Biotest Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Biotest Prophylactic Gamma Globulin Product Portfolio Table 148. Biotest Recent Development Table 149. ADMA Biologics Company Information Table 150. ADMA Biologics Business Overview Table 151. ADMA Biologics Prophylactic Gamma Globulin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. ADMA Biologics Prophylactic Gamma Globulin Product Portfolio Table 153. ADMA Biologics Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Prophylactic Gamma Globulin Distributors List Table 157. Prophylactic Gamma Globulin Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Prophylactic Gamma Globulin Product Image Figure 2. Global Prophylactic Gamma Globulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prophylactic Gamma Globulin Sales (2021-2032) & (k units) Figure 5. Global Prophylactic Gamma Globulin Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prophylactic Gamma Globulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. IVIg Liquid Image Figure 10. IVIg Powder Image Figure 11. Global Prophylactic Gamma Globulin Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Prophylactic Gamma Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Prophylactic Gamma Globulin Sales Volume Share by Type (2021-2032) Figure 14. Global Prophylactic Gamma Globulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Prophylactic Gamma Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Prophylactic Gamma Globulin Sales Value Share by Type (2021-2032) Figure 17. Autoimmune Disease Image Figure 18. Immunodeficiency Image Figure 19. Acute Infection Image Figure 20. Global Prophylactic Gamma Globulin Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Prophylactic Gamma Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Prophylactic Gamma Globulin Sales Volume Share by Application (2021-2032) Figure 23. Global Prophylactic Gamma Globulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Prophylactic Gamma Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Prophylactic Gamma Globulin Sales Value Share by Application (2021-2032) Figure 26. Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Prophylactic Gamma Globulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Prophylactic Gamma Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Prophylactic Gamma Globulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Prophylactic Gamma Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Prophylactic Gamma Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Prophylactic Gamma Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Prophylactic Gamma Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Prophylactic Gamma Globulin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Prophylactic Gamma Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Prophylactic Gamma Globulin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Prophylactic Gamma Globulin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • CNBG
  • Takeda
  • Shenzhen Weiguang Biological
  • Beijing Tiantan Biological
  • CBPO
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Pacific Shuanglin Bio-pharmacy
  • Grifols
  • Hualan Biological
  • Beijing Bohui Innovation Biotechnology
  • Baxter
  • Octapharma
  • LFB Group
  • Kedrion Biopharma
  • BPL
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prophylactic Gamma Globulin Sales Value (2021-2032)
  4. 1.2.2 Global Prophylactic Gamma Globulin Sales Volume (2021-2032)
  5. 1.2.3 Global Prophylactic Gamma Globulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prophylactic Gamma Globulin Market Dynamics
  1. 2.1 Prophylactic Gamma Globulin Industry Trends
  2. 2.2 Prophylactic Gamma Globulin Industry Drivers
  3. 2.3 Prophylactic Gamma Globulin Industry Opportunities and Challenges
  4. 2.4 Prophylactic Gamma Globulin Industry Restraints
3 Prophylactic Gamma Globulin Market by Company
  1. 3.1 Global Prophylactic Gamma Globulin Company Revenue Ranking in 2025
  2. 3.2 Global Prophylactic Gamma Globulin Revenue by Company (2021-2026)
  3. 3.3 Global Prophylactic Gamma Globulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Prophylactic Gamma Globulin Average Price by Company (2021-2026)
  5. 3.5 Global Prophylactic Gamma Globulin Company Ranking (2024-2026)
  6. 3.6 Global Prophylactic Gamma Globulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Prophylactic Gamma Globulin Company Product Type and Application
  8. 3.8 Global Prophylactic Gamma Globulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prophylactic Gamma Globulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prophylactic Gamma Globulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prophylactic Gamma Globulin Market by Type
  1. 4.1 Prophylactic Gamma Globulin Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Prophylactic Gamma Globulin Sales Volume by Type
  5. 4.2.1 Global Prophylactic Gamma Globulin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prophylactic Gamma Globulin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Prophylactic Gamma Globulin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Prophylactic Gamma Globulin Sales Value by Type
  9. 4.3.1 Global Prophylactic Gamma Globulin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Prophylactic Gamma Globulin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Prophylactic Gamma Globulin Sales Value Share by Type (2021-2032)
5 Prophylactic Gamma Globulin Market by Application
  1. 5.1 Prophylactic Gamma Globulin Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Prophylactic Gamma Globulin Sales Volume by Application
  6. 5.2.1 Global Prophylactic Gamma Globulin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prophylactic Gamma Globulin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Prophylactic Gamma Globulin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Prophylactic Gamma Globulin Sales Value by Application
  10. 5.3.1 Global Prophylactic Gamma Globulin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prophylactic Gamma Globulin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Prophylactic Gamma Globulin Sales Value Share by Application (2021-2032)
6 Prophylactic Gamma Globulin Regional Sales and Value Analysis
  1. 6.1 Global Prophylactic Gamma Globulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prophylactic Gamma Globulin Sales by Region (2021-2032)
  3. 6.2.1 Global Prophylactic Gamma Globulin Sales by Region: 2021-2026
  4. 6.2.2 Global Prophylactic Gamma Globulin Sales by Region (2027-2032)
  5. 6.3 Global Prophylactic Gamma Globulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prophylactic Gamma Globulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prophylactic Gamma Globulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prophylactic Gamma Globulin Sales Value by Region (2027-2032)
  9. 6.5 Global Prophylactic Gamma Globulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prophylactic Gamma Globulin Sales Value (2021-2032)
  12. 6.6.2 North America Prophylactic Gamma Globulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prophylactic Gamma Globulin Sales Value (2021-2032)
  15. 6.7.2 Europe Prophylactic Gamma Globulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prophylactic Gamma Globulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prophylactic Gamma Globulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prophylactic Gamma Globulin Sales Value (2021-2032)
  21. 6.9.2 South America Prophylactic Gamma Globulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prophylactic Gamma Globulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prophylactic Gamma Globulin Sales Value Share by Country, 2025 VS 2032
7 Prophylactic Gamma Globulin Country-level Sales and Value Analysis
  1. 7.1 Global Prophylactic Gamma Globulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prophylactic Gamma Globulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prophylactic Gamma Globulin Sales by Country (2021-2032)
  4. 7.3.1 Global Prophylactic Gamma Globulin Sales by Country (2021-2026)
  5. 7.3.2 Global Prophylactic Gamma Globulin Sales by Country (2027-2032)
  6. 7.4 Global Prophylactic Gamma Globulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prophylactic Gamma Globulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prophylactic Gamma Globulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prophylactic Gamma Globulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prophylactic Gamma Globulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prophylactic Gamma Globulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CNBG
  2. 8.1.1 CNBG Company Information
  3. 8.1.2 CNBG Business Overview
  4. 8.1.3 CNBG Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CNBG Prophylactic Gamma Globulin Product Portfolio
  6. 8.1.5 CNBG Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Prophylactic Gamma Globulin Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Shenzhen Weiguang Biological
  14. 8.3.1 Shenzhen Weiguang Biological Company Information
  15. 8.3.2 Shenzhen Weiguang Biological Business Overview
  16. 8.3.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product Portfolio
  18. 8.3.5 Shenzhen Weiguang Biological Recent Developments
  19. 8.4 Beijing Tiantan Biological
  20. 8.4.1 Beijing Tiantan Biological Company Information
  21. 8.4.2 Beijing Tiantan Biological Business Overview
  22. 8.4.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Product Portfolio
  24. 8.4.5 Beijing Tiantan Biological Recent Developments
  25. 8.5 CBPO
  26. 8.5.1 CBPO Company Information
  27. 8.5.2 CBPO Business Overview
  28. 8.5.3 CBPO Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CBPO Prophylactic Gamma Globulin Product Portfolio
  30. 8.5.5 CBPO Recent Developments
  31. 8.6 Sichuan Yuanda Shuyang
  32. 8.6.1 Sichuan Yuanda Shuyang Company Information
  33. 8.6.2 Sichuan Yuanda Shuyang Business Overview
  34. 8.6.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product Portfolio
  36. 8.6.5 Sichuan Yuanda Shuyang Recent Developments
  37. 8.7 Shanghai RAAS
  38. 8.7.1 Shanghai RAAS Company Information
  39. 8.7.2 Shanghai RAAS Business Overview
  40. 8.7.3 Shanghai RAAS Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai RAAS Prophylactic Gamma Globulin Product Portfolio
  42. 8.7.5 Shanghai RAAS Recent Developments
  43. 8.8 Pacific Shuanglin Bio-pharmacy
  44. 8.8.1 Pacific Shuanglin Bio-pharmacy Company Information
  45. 8.8.2 Pacific Shuanglin Bio-pharmacy Business Overview
  46. 8.8.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product Portfolio
  48. 8.8.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Prophylactic Gamma Globulin Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 Hualan Biological
  56. 8.10.1 Hualan Biological Company Information
  57. 8.10.2 Hualan Biological Business Overview
  58. 8.10.3 Hualan Biological Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Biological Prophylactic Gamma Globulin Product Portfolio
  60. 8.10.5 Hualan Biological Recent Developments
  61. 8.11 Beijing Bohui Innovation Biotechnology
  62. 8.11.1 Beijing Bohui Innovation Biotechnology Company Information
  63. 8.11.2 Beijing Bohui Innovation Biotechnology Business Overview
  64. 8.11.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product Portfolio
  66. 8.11.5 Beijing Bohui Innovation Biotechnology Recent Developments
  67. 8.12 Baxter
  68. 8.12.1 Baxter Company Information
  69. 8.12.2 Baxter Business Overview
  70. 8.12.3 Baxter Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Prophylactic Gamma Globulin Product Portfolio
  72. 8.12.5 Baxter Recent Developments
  73. 8.13 Octapharma
  74. 8.13.1 Octapharma Company Information
  75. 8.13.2 Octapharma Business Overview
  76. 8.13.3 Octapharma Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Octapharma Prophylactic Gamma Globulin Product Portfolio
  78. 8.13.5 Octapharma Recent Developments
  79. 8.14 LFB Group
  80. 8.14.1 LFB Group Company Information
  81. 8.14.2 LFB Group Business Overview
  82. 8.14.3 LFB Group Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 LFB Group Prophylactic Gamma Globulin Product Portfolio
  84. 8.14.5 LFB Group Recent Developments
  85. 8.15 Kedrion Biopharma
  86. 8.15.1 Kedrion Biopharma Company Information
  87. 8.15.2 Kedrion Biopharma Business Overview
  88. 8.15.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Kedrion Biopharma Prophylactic Gamma Globulin Product Portfolio
  90. 8.15.5 Kedrion Biopharma Recent Developments
  91. 8.16 BPL
  92. 8.16.1 BPL Company Information
  93. 8.16.2 BPL Business Overview
  94. 8.16.3 BPL Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BPL Prophylactic Gamma Globulin Product Portfolio
  96. 8.16.5 BPL Recent Developments
  97. 8.17 Biotest
  98. 8.17.1 Biotest Company Information
  99. 8.17.2 Biotest Business Overview
  100. 8.17.3 Biotest Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Biotest Prophylactic Gamma Globulin Product Portfolio
  102. 8.17.5 Biotest Recent Developments
  103. 8.18 ADMA Biologics
  104. 8.18.1 ADMA Biologics Company Information
  105. 8.18.2 ADMA Biologics Business Overview
  106. 8.18.3 ADMA Biologics Prophylactic Gamma Globulin Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 ADMA Biologics Prophylactic Gamma Globulin Product Portfolio
  108. 8.18.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prophylactic Gamma Globulin Value Chain Analysis
  2. 9.1.1 Prophylactic Gamma Globulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prophylactic Gamma Globulin Sales Mode & Process
  6. 9.2 Prophylactic Gamma Globulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prophylactic Gamma Globulin Distributors
  9. 9.2.3 Prophylactic Gamma Globulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst